<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FDE88BD1-B428-40D5-918B-6443E9904AE8"><gtr:id>FDE88BD1-B428-40D5-918B-6443E9904AE8</gtr:id><gtr:name>Autism Speaks</gtr:name><gtr:address><gtr:line1>Autism Speaks</gtr:line1><gtr:line2>North Lea House</gtr:line2><gtr:line3>66 Northfield End</gtr:line3><gtr:postCode>RG9 2BE</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Neurosciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FDE88BD1-B428-40D5-918B-6443E9904AE8"><gtr:id>FDE88BD1-B428-40D5-918B-6443E9904AE8</gtr:id><gtr:name>Autism Speaks</gtr:name><gtr:address><gtr:line1>Autism Speaks</gtr:line1><gtr:line2>North Lea House</gtr:line2><gtr:line3>66 Northfield End</gtr:line3><gtr:postCode>RG9 2BE</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F4949C7B-6475-4F41-A9ED-1AFB010B6914"><gtr:id>F4949C7B-6475-4F41-A9ED-1AFB010B6914</gtr:id><gtr:firstName>Olaf</gtr:firstName><gtr:surname>Ansorge</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL022656%2F1"><gtr:id>980CC062-BCE5-4A80-B932-D4A1AE276830</gtr:id><gtr:title>MRC Brain Banks: Joint Application to Underpin Neuroscience Research</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L022656/1</gtr:grantReference><gtr:abstractText>This application plans to support research into the causes and potential treatment of a range of diseases affecting the
brain, some of which have been identified as priorities for research, such as dementia. The UK has a network of
established Brain Banks that provide human tissue samples to a wide range of researchers. Human tissue samples have
allowed a better understanding of the mechanisms operating in these complex disorders and have already aided the
development of treatments for Alzheimer's disease and Parkinson's disease.
This application will support four Brain Banks in Edinburgh, London, Newcastle and Oxford. These banks each have areas
of particular interest, Parkinson's disease, Alzheimer's disease and motor neurone disease. However, in addition to the
collection of tissues samples from patients with brain disorders, it is also essential to collect normal tissue samples for use
as controls in research. Two of the Banks have a major focus in this area, so this application will support the collection of
both disease and normal tissue samples.
The banks will support scientific research by providing human tissue samples in an efficient and cost effective manner,
while ensuring the samples provided are of the high quality required by researchers. The banks have worked to improve
their efficiency, reducing the time required to provide the samples to researchers. Details of the samples available in each
of the banks are included in a database, which is accessible through the internet. This allows researchers to see what
samples are available and how to request these samples for their research in an easy way that will save time and speed up
progress.
All four Brain Banks in this application have approval form an Ethics Committee, to ensure that their working practices meet
nationally agreed standards that apply to work with human tissue samples. The work of each Bank is overseen by a local
steering committee that includes members of the public and ethics experts as well as scientists and pathologists. Brain
Banking is expensive, but the operating costs of these four banks are far less than their equivalents in Europe and in the
USA.
The challenges of developing treatments for complex diseases such as Alzheimer's disease and Parkinson's disease are
considerable, but the Brain Banks in this application will play an important role in underpinning the scientific research in
these national priority areas.</gtr:abstractText><gtr:technicalSummary>This joint application from the MRC Brain Banks in Edinburgh, London, Newcastle and Oxford is submitted in accordance
with the wishes of the MRC Neuroscience and Mental Health Board (NMHB). After the last funding round for the MRC
Brain Banks in 2011, NMHB indicated that a future joint application would be preferred and that the applicants should
demonstrate progress in efficiency and improving standards of work in accordance with an agreed set of metrics. This
application fulfils this request, and aims to underpin neuroscience research in the UK by providing high-quality human brain
tissue samples and data in the formats required by researchers in both academic and industrial settings. The four banks in
this application together cover the collection of human tissue samples from a range of major neurological diseases, and
normal tissue samples to act as controls. This provides an invaluable resource to underpin neuroscience research in UK,
particularly in recently identified priority areas such as dementia.
The banks have demonstrated in this application that they can work to the standards set in the metrics agreed with the
NMHB, and have improved their efficiency of operations. The banks already support a number of major researchers in
academia and industry in UK and overseas, including several who are currently funded by MRC. The provision of high
quality tissue samples and accompanying data is essential for the success of these projects; the MRC brain banks
constitute a critical infrastructure for this research.
In order to develop this important work further, funding for a 5 year period is requested; earlier funding awards for periods
of 2 years has not been conducive to long term planning and strategy. The costs of brain banking in the UK compare very
favourably with those in Europe and in the USA; over the next 5 years the banks will continue to work to improve efficiency
of operation and to operate a cost recovery programme in keeping with MR</gtr:technicalSummary><gtr:potentialImpactText>The activities of the brain banks will be of major significance to neuroscience researchers in the UK and the banks plan to
capitalise upon this by promoting the availability of their tissue samples during the course of this grant, primarily by the
MRC database, which will give details of all samples currently available, including control samples. This promotion will not
be confined to academic researchers, but also through the Association of British Pharmaceutical Industries the applicants
will promote the availability of the tissue samples in their banks and will engage with both academic and industrial
researchers to help provide the samples they require.
The brain banks already supply tissue samples to commercial companies for their research and development purposes and
it is planned to continue and develop these contacts within an appropriate framework.
The applicants are involved in a number of local, national and international committees and bodies that relate to research.
Policymakers within both government (DH) and non-governmental organisations and regulators (e.g. the Human Tissue
Authority) will benefit from information arising from the use of human brain tissue samples and also from the general
promotion of brain donation in neuroscience research.
The applicants have previously engaged with museums (including the Wellcome Trust museum) and charities including the
Alzheimer's Society, Alzheimer's Research UK, the Multiple Sclerosis Society and Parkinson's UK to provide expert advice
on brain banking. The applicants also work within the committee structure of these charities to advise on their research
activities, particularly those that might involve the collection and use of human tissue samples.
The wider public is likely to benefit from this planned research, particularly if the tissue samples provided result in improved
diagnosis or treatment for patients with neurodegenerative disorders. Furthermore, the promotion of brain banking and the
value of brain donation for research will help raise public awareness of the challenges of dementia and neurodegenerative
diseases, and help make individuals take an informed choice on this complex matter.
It is likely that the government may benefit from this research, particularly in respect to the activities of the Ministerial Action
Group on Dementia Research and the Prime Minister's Challenge on dementia, within which brain banking is
acknowledged as an essential requirement to support researchers in this field. The support requested in this application
will be of wider benefit to these government initiatives and the research arising from this work, supported by other
government funded bodies including NIHR.
Finally, MRC is likely to benefit from this research, since the applicants already provide large numbers of tissue samples to
researchers such as Professor John Hardy, UCL, who are in receipt of significant funding from MRC to undertake research
projects that are critically dependent on a continuous supply of high quality tissue samples that will be collected and made
available during the course of this proposal.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1007801</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neuropathology and Ocular Pathology</gtr:department><gtr:description>National Health Service</gtr:description><gtr:id>FE3A35F0-124C-4932-B4AF-699F81B11AF6</gtr:id><gtr:impact>Integrated Neuropathology resource bringing together accurate neuropathological diagnostic, material resources and dissemination of research samples.</gtr:impact><gtr:outcomeId>S2RiPC8y9F7-1</gtr:outcomeId><gtr:partnerContribution>diagnostic services and shared facilities / equipment.</gtr:partnerContribution><gtr:piContribution>storage and research use of donated biological samples</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autism Speaks</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Autism BrainNet</gtr:department><gtr:description>Autism BrainNet</gtr:description><gtr:id>4B69A403-57B9-4EAF-8641-CF1A7A313B69</gtr:id><gtr:impact>Partnership starting January 2015</gtr:impact><gtr:outcomeId>5464c45678cfb5.34638024-1</gtr:outcomeId><gtr:partnerContribution>Funding will be provided on a per brain basis for retrieving and making the tissue available to the network for research.</gtr:partnerContribution><gtr:piContribution>Autism BrainNet have offered the Oxford Brain Bank the opportunity to become the first non-USA node of the Autism BrainNet network, with a start date of 1st January 2015. 
The tissue to be retrieved includes brains from patients with Autism and other related developmental diseases, as well as young controls with sudden death or diseases outside the nervous system.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuropathology Unit</gtr:department><gtr:description>MRC Brain Bank Network</gtr:description><gtr:id>C42CDF01-CA90-4B17-ABFC-929C58C60359</gtr:id><gtr:impact>Freely available online tissue repository via an MRC network database.</gtr:impact><gtr:outcomeId>jsjqQmdSiDL-1</gtr:outcomeId><gtr:partnerContribution>The network partners contribute IT and management expertise to our project. Partners also contribute research protocols.</gtr:partnerContribution><gtr:piContribution>This grant (G1000691) is for the establishment of a new brain bank for neuroscience research. Part of our work is an active contribution to the emerging MRC brain bank network. This includes contributions to network-wide developments for protocol refinement, consensus sampling protocols and diagnostic criteria. We are also actively contributing to an online tissue repository accessible by any intererested neuroscience researcher.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Visit from The London International Youth Science Forum (LIYSF)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ED68C657-413A-4289-9CF9-2BE6127BAEC9</gtr:id><gtr:impact>LIYSF is a two week residential event held at Imperial College London, with lectures and demonstrations from leading scientists, visits to industrial sites, research centres, scientific institutions and organisations, including world class laboratories and universities.

LIYSF attracts 500 of the world's leading young scientists aged 17-21 years old from more than 65 participating countries. There is an active social calendar with events designed to enable those from around the world to learn about different cultures. The scope of LIYSF extends further than broadening scientific understanding to engage students in education on other cultures and develop lasting, international friendships.

30 students visited the Neuropathology laboratory and enjoyed a teaching session on brain anatomy and pathology with Dr Ansorge.</gtr:impact><gtr:outcomeId>56e14fe2ac4c03.94233982</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:url>http://www.liysf.org.uk/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Autism Research Oxford Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FCBC6AD0-AE82-479D-B41B-142A92DAC6FF</gtr:id><gtr:impact>Workshop gave rise to an offer by Autism BrainNet for Oxford Brain Bank to join their network, and served as a platform for discussing Autism Research in Oxford

Dr Ansorge invited Autism BrainNet's project manager to visit the Oxford Brain Bank facilities, she visited in July. Dr Ansorge then visited the facilities of the New York node of the network and met up with all other node directors.</gtr:impact><gtr:outcomeId>5464c574a38f18.84646475</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Brain Bank Open Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>286C142D-69AF-4E3F-AB1D-6B28BB2586A2</gtr:id><gtr:impact>80 participants visited the Oxford Brain Bank. During the day they attended a talk about tissue banking by Dr Ansorge, visited the Neuropathology laboratory and were shown brain anatomy and how Alzheimer's disease affects brain morphology with Professor Esiri, learnt about tissue preparation with Oxford Brain Bank technicians, looked at brain pathology down the microscope with Dr Ansorge, learnt about new techniques and equipment in tissue banking with Connor Scott, and talked about research outputs and research projects with Dr De Luca.

The participants were very enthusiastic about the event and many reported wanting to engage more with the Oxford Brain Bank and to read more about research outputs related to brain and spinal cord donation. Several relatives of donors were present and reported a greater understanding of the processes that follow brain donation.</gtr:impact><gtr:outcomeId>56e150ff395c19.82380060</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Test For Parkinson's Disease Moves Step Closer</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9F346190-2713-4FDC-9A26-E447DCD20405</gtr:id><gtr:impact>Media article printed on BBC website.</gtr:impact><gtr:outcomeId>58c96a11222f81.81483505</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-37196619</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Awareness Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1F84337C-EB3A-4FB7-97F8-1C4827F4B2E4</gtr:id><gtr:impact>An afternoon of interactive activities with Oxford researchers and students from Oxford University Cortex Club as part of Brain Awareness Week. Drop-in suitable for children aged 6 upwards. 

The activities ranged from video games explaining the pathophysiology of Alzheimers Disease, to live microscope and EEG demonstrations.</gtr:impact><gtr:outcomeId>58c969910774f1.85680238</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.mhs.ox.ac.uk/gastrophysics-brain-aware/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Bbank Network Donation Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DA57CD8D-E4C1-417A-B014-5AD13593037E</gtr:id><gtr:impact>Very useful workshop concerning potential, risks, experiences and ethical considerations about UK brain banking. Discussion with funders, users and scientists.

Development of a coherent strategy for UK brain tissue banking for neuroscience research.</gtr:impact><gtr:outcomeId>TvJNgs5o76X</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Association for Tissue Banking</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B8DE43E8-EAAD-4438-946B-37CA32C48237</gtr:id><gtr:impact>Presentation of rationale, ethical framework and strategy for brain banking to the national annual meeting of the BATB.

Better integration of tissue donation for transplant and research. Understanding that these two activities can be linked.</gtr:impact><gtr:outcomeId>cXfDju25CFs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Q&amp;A</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>627565CE-AD6D-4394-88F5-E9B84B9906A8</gtr:id><gtr:impact>Science Oxford screened the Oscar-nominated documentary Life, Animated - A mix of animated storytelling and real life narration that doesn't flinch from exploring the emotional highs and lows that accompany a life with autism. The screening was &amp;quot;followed by a talk by University of Oxford neuroscience expert Steven Chance&amp;quot;. SThe Ultimate Picture Palace and Science Oxford invited him to speak and do Q&amp;amp;A. Over 80 people in the audience attended for the Q&amp;amp;A and asked questions. As a result he has also been invited to speak at a secondary school by one of the teachers who attended.</gtr:impact><gtr:outcomeId>58ca79b6a426a3.42626892</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Parkinson's UK group site visit</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>518E8D3A-14BF-4E24-9B86-B73306DE66AF</gtr:id><gtr:impact>&amp;quot;Value of brain banking and what Neuropathology can teach us about Parkinson's disease?&amp;quot;

Oxford Parkinson's disease group are now aware of and supportive of brain banking efforts</gtr:impact><gtr:outcomeId>546607b7644c70.50892343</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Disease Local Branch Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FA83D8F5-6FF9-432D-89BF-C6989E002B5F</gtr:id><gtr:impact>Education of patients and relatives as well as health care professionals about the impact brain tissue research has made on our understanding of the pathobiology of Parkinson's disease and other degenerative conditions.

Raised public awareness of our project.</gtr:impact><gtr:outcomeId>FDpMeGeoAd5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIHR BRC Oxford Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0619F23A-8487-4BAF-8CCC-A1F7FE02A5F8</gtr:id><gtr:impact>Presentation to the public of the link between researching and understanding common brain diseases and human brain tissue donation.

Increase in enquiries about brain tissue donation by memebers of the public.</gtr:impact><gtr:outcomeId>RzYfishDfVX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer Research UK Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2E12F547-AB1B-4DDF-8E73-53C0BF5A1CF4</gtr:id><gtr:impact>A full day with ~150 attendees about clinical and 'translational' brain research with a focus on dementia. Presentation and discussion on the importance of brain banking to understand pathogenesis and outcomes of treatments etc.

Interest by the public to explore tissue donation - reflected in pick-up of leaflets and discussions.</gtr:impact><gtr:outcomeId>QdMoRZiw7CW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>498000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Brains for Dementia Research</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Alzheimer?s Brain Bank UK (ABBUK)</gtr:fundingOrg><gtr:id>C5138294-0F51-4951-AA85-AAE32BC19469</gtr:id><gtr:outcomeId>Yz84cH2pKba</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Tissue Donation in the OUH Hospitals</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>BFEAC70A-27B3-4500-99AD-DC4FD25CD160</gtr:id><gtr:impact>Staff training and patient information concerning tissue donation after death has been rolled out across the OUH Hospitals as a result of our project.</gtr:impact><gtr:outcomeId>Kg8fNud3QDi</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>This is a database of all brain, spinal cord and peripheral organ tissue available for research within the Oxford Brain Bank's Thomas Willis Brain Collection. The archive contains over 6,000 cases from the 1960s to present. The data is available to researchers through Brain UK.</gtr:description><gtr:id>756DA675-8EC2-4E47-9709-B1CC3740E8E0</gtr:id><gtr:impact>We regularly receive requests from researchers for tissue of patients with rare conditions</gtr:impact><gtr:outcomeId>5464c6f9003e10.95452491</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Thomas Willis Brain Collection database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The principle aim of this research project (G1000691) is to provide national and international researchers with high-quality biological samples with associated clinical and quality data.</gtr:description><gtr:id>D08B3495-0066-4941-AE9C-2DE19253264A</gtr:id><gtr:impact>Tissue is being used in a range of projects by academic and industry partners. Output data (samples etc) are available through a regulated requesting system.</gtr:impact><gtr:outcomeId>QPFuAuDYZTf</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Brain and spinal cord Tissue for Research</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocol for systematic, rapid freezing of anatomically preserved slices of human brain tissue using a liquid nitrogen vapour storage/transportation dewar.</gtr:description><gtr:id>3FB9802C-01B8-4434-A5BA-F0AA24BE7262</gtr:id><gtr:impact>Pilot analysis suggests greater preservation of microscopic anatomy and no ice crystal artefacts.
Accurate dissection of frozen region of interest facilitated by preserved anatomy of coronal slices.
Freezing method adopted or about to be adopted by other centres (Edinburgh, Autism BrainNet nodes)</gtr:impact><gtr:outcomeId>Hnw9rRpf5DG</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Liquid nitrogen vapour freezing</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D886C45D-CD0E-4061-8DF0-DF29C4C4E527</gtr:id><gtr:title>PP52. RAMAN SPECTROSCOPY FOR THE IDENTIFICATION OF ISOCITRATE DEHYDROGENASE (IDH) MUTATED GLIOBLASTOMAS</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67998feb1a3781c1a6de85fbc633a2ba"><gtr:id>67998feb1a3781c1a6de85fbc633a2ba</gtr:id><gtr:otherNames>Livermore M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa616265d911.98336704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D233318-1307-42A0-852F-5D5D8CF4F44F</gtr:id><gtr:title>Wider minicolumns in autism: a neural basis for altered processing?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34b38065dd9a2cc51310f8a95ee24a13"><gtr:id>34b38065dd9a2cc51310f8a95ee24a13</gtr:id><gtr:otherNames>McKavanagh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56e15f38dd7fe7.42680686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E5948E0-0501-440D-9586-DE2E3D435368</gtr:id><gtr:title>Subventricular zone cytoarchitecture changes in autism.</gtr:title><gtr:parentPublicationTitle>Developmental neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab407e29263d8cc81e579d1d88705a9"><gtr:id>cab407e29263d8cc81e579d1d88705a9</gtr:id><gtr:otherNames>Kotagiri P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-8451</gtr:issn><gtr:outcomeId>56e15f39ab04c8.81976797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22696A2F-1033-4FF7-8FCD-BF1C46FD177C</gtr:id><gtr:title>Role of membrane complement regulators in neuromyelitis optica.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis (Houndmills, Basingstoke, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/534f5a26ffd285a446def8efb717fc0d"><gtr:id>534f5a26ffd285a446def8efb717fc0d</gtr:id><gtr:otherNames>Saadoun S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1352-4585</gtr:issn><gtr:outcomeId>56e15f33d7bf95.02026041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E8BDC0A-E6E4-4C7C-AB9A-7CCFE5149DA0</gtr:id><gtr:title>The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45dcb489b922a4b247359b65e3e89f88"><gtr:id>45dcb489b922a4b247359b65e3e89f88</gtr:id><gtr:otherNames>Yates RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f358cb9d5.71284416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51615414-BFFF-468D-8B2E-67891E5B3CF4</gtr:id><gtr:title>Neuropathology of the anterior midcingulate cortex in young children with autism.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2493c488836033b9bd7bd773a0f49752"><gtr:id>2493c488836033b9bd7bd773a0f49752</gtr:id><gtr:otherNames>Uppal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>56e15f3b40b782.53175923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8331198E-D9AA-4CCC-A733-589FFC34CEC9</gtr:id><gtr:title>Calretinin interneuron density in the caudate nucleus is lower in autism spectrum disorder.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9581a28b9ff7d514c3e7885185f09568"><gtr:id>9581a28b9ff7d514c3e7885185f09568</gtr:id><gtr:otherNames>Adorjan I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aaa57a9d93a31.70117305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>804DE8EA-9BE7-4E62-BB63-85889A1A2184</gtr:id><gtr:title>Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/885720bc2226a85365e40965e4f8cf19"><gtr:id>885720bc2226a85365e40965e4f8cf19</gtr:id><gtr:otherNames>Gerenu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5aaa57a9b0e745.55612572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A016DCB9-6DC5-4B4F-A930-6AEFE2F55AFE</gtr:id><gtr:title>Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45dcb489b922a4b247359b65e3e89f88"><gtr:id>45dcb489b922a4b247359b65e3e89f88</gtr:id><gtr:otherNames>Yates RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>5aaa5dba55e1f9.86070588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE9251D3-7FCB-4CF5-A0CB-7D65D6870C15</gtr:id><gtr:title>Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4cf10cb9e564a50071bfd04181c0dcc"><gtr:id>b4cf10cb9e564a50071bfd04181c0dcc</gtr:id><gtr:otherNames>Esiri MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>5464c2803ac816.53050995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3013BEE0-4017-4C53-886D-FB57A33B94A7</gtr:id><gtr:title>Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d82cea2455b997724bf26606df3e21db"><gtr:id>d82cea2455b997724bf26606df3e21db</gtr:id><gtr:otherNames>Baruch K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56e15f327b07e5.22186819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC263699-D467-4D24-924D-F4D8AA916BD4</gtr:id><gtr:title>Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bb1df96eb6c522533fcf07eeb565f27"><gtr:id>4bb1df96eb6c522533fcf07eeb565f27</gtr:id><gtr:otherNames>Fairfoul G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>58c7f3b51be9b9.64355550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E0A0BAF-4A23-4EC0-AFB0-508C262DB49D</gtr:id><gtr:title>Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59aaa585a09d2d24ba227a6eb8dc0d40"><gtr:id>59aaa585a09d2d24ba227a6eb8dc0d40</gtr:id><gtr:otherNames>DeLuca GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56e15f330a9666.46765057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8B45926-791E-4525-94C6-FF33D7B04AD5</gtr:id><gtr:title>Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/609865d4dd5b805590a0ed599a30249b"><gtr:id>609865d4dd5b805590a0ed599a30249b</gtr:id><gtr:otherNames>Bras J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5464c08ed5ff46.68183626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>143FB27A-5871-4FA2-9C11-7E0AACF6B792</gtr:id><gtr:title>Patterns and pathways of calcification in the developing brain.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/331b5f3cdc84ae64fbdcb85553795b45"><gtr:id>331b5f3cdc84ae64fbdcb85553795b45</gtr:id><gtr:otherNames>McCartney E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>56e15f3570f2d6.17869431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71A0063E-2C53-444E-BC93-326ED33F7FB1</gtr:id><gtr:title>Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e15f38c020b1.76390313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27F70230-B865-4D51-8ECD-2C41262301EB</gtr:id><gtr:title>DNA damage response and senescence in endothelial cells of human cerebral cortex and relation to Alzheimer's neuropathology progression: a population-based study in the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c58c64d02a3edc3d0ae27f66455b7e2"><gtr:id>6c58c64d02a3edc3d0ae27f66455b7e2</gtr:id><gtr:otherNames>Garwood CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f37bb71a8.19811505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78AB8C0A-9801-4F54-863D-F509ACDFB8BD</gtr:id><gtr:title>Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31594fee78e089b35944df37e6703da7"><gtr:id>31594fee78e089b35944df37e6703da7</gtr:id><gtr:otherNames>Larkin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>5464c08e65bc90.51373523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F54AEE0E-494B-4758-B871-FB3CD4D576D1</gtr:id><gtr:title>a-synuclein genetic variability: A biomarker for dementia in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0da82446ca4fdf3592989b8d4f31cb53"><gtr:id>0da82446ca4fdf3592989b8d4f31cb53</gtr:id><gtr:otherNames>Guella I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c960a70d6ee9.25241706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C63C31DD-97C0-4F5D-BE30-1A97B96B655A</gtr:id><gtr:title>Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5aaa5db825c405.75272753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBDC558D-7043-408C-BB4F-9B4FEFF6F2CE</gtr:id><gtr:title>Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56e15f3bb5bb64.12651659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6C995D-9BF2-4642-A56C-E064A82E7DB3</gtr:id><gtr:title>Clusterin associates specifically with A?40 in Alzheimer's disease brain tissue.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1da287f55a621cd5e9876bc34531117"><gtr:id>e1da287f55a621cd5e9876bc34531117</gtr:id><gtr:otherNames>Howlett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56e15f37235fe4.57832847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28ADAD4F-7C54-4274-BE67-4A8918C178AB</gtr:id><gtr:title>Break with tradition: donating cadavers for scientific purposes and reducing the use of sentient beings.</gtr:title><gtr:parentPublicationTitle>Annali dell'Istituto superiore di sanita</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a5b0e295035b32c685625f1c9832ae2"><gtr:id>8a5b0e295035b32c685625f1c9832ae2</gtr:id><gtr:otherNames>Ciliberti R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-2571</gtr:issn><gtr:outcomeId>58c96317092bf8.53436058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC5BC511-43D5-4DE7-90C3-E94E87CBADF3</gtr:id><gtr:title>The histopathology of polymicrogyria: a series of 71 brain autopsy studies.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e70813c73adee4d472b49b98bd7ab8c4"><gtr:id>e70813c73adee4d472b49b98bd7ab8c4</gtr:id><gtr:otherNames>Jansen AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>58c963cb7fb263.79914893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E36B502-D26D-4E39-A854-D155D57D06C6</gtr:id><gtr:title>A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f3c0a1b01.15480183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78EDEFE5-EB36-43E8-BDB5-6C5706848468</gtr:id><gtr:title>CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11558ca688574360e413c95a4ca96865"><gtr:id>11558ca688574360e413c95a4ca96865</gtr:id><gtr:otherNames>Solas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e15f374372f4.15109904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD223F0C-86BC-452B-8080-92547C9E6D80</gtr:id><gtr:title>Olfactory Pathology in Central Nervous System Demyelinating Diseases.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59aaa585a09d2d24ba227a6eb8dc0d40"><gtr:id>59aaa585a09d2d24ba227a6eb8dc0d40</gtr:id><gtr:otherNames>DeLuca GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5464c280a8b911.54268451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61E8E4DE-1AB7-45DF-B046-A240BEA24989</gtr:id><gtr:title>Unfolded protein response is activated in Lewy body dementias.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a7a5c519de42b38187e2dc3bf1f9516"><gtr:id>2a7a5c519de42b38187e2dc3bf1f9516</gtr:id><gtr:otherNames>Baek JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f38670a15.76429553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD0B95B0-1A95-41F0-B79D-00B1F716C525</gtr:id><gtr:title>Locus ceruleus neurons in people with autism contain no histochemically-detectable mercury.</gtr:title><gtr:parentPublicationTitle>Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d5f44717a4788447640a79d2e854f8c"><gtr:id>5d5f44717a4788447640a79d2e854f8c</gtr:id><gtr:otherNames>Pamphlett R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0966-0844</gtr:issn><gtr:outcomeId>56e15f31ccb350.05230015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E173DD3-0730-4290-A874-03BE61A03F4A</gtr:id><gtr:title>JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31820c3459d3459acfbf8d419b58b6b2"><gtr:id>31820c3459d3459acfbf8d419b58b6b2</gtr:id><gtr:otherNames>Rodriguez-Perdigon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>58c96189d707d2.91513305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEA03633-8F75-40BF-8998-E41F47D63F24</gtr:id><gtr:title>Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>5aaa5db89c4fe0.47386415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5851225-6496-4B19-BBC1-84C45FD7F73E</gtr:id><gtr:title>Stage-specific changes in neurogenic and glial markers in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2390a332c9de21dee0b9e94eaeeb4d7b"><gtr:id>2390a332c9de21dee0b9e94eaeeb4d7b</gtr:id><gtr:otherNames>Ekonomou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>56e15f3b603244.98197263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>294B4AF9-F011-4793-B5A4-8F7E29D40E14</gtr:id><gtr:title>Induction of the cell survival kinase Sgk1: A possible novel mechanism for a-phenyl-N-tert-butyl nitrone in experimental stroke.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fd7b81d706dc804540be08c3dee655a"><gtr:id>6fd7b81d706dc804540be08c3dee655a</gtr:id><gtr:otherNames>McCaig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>5aaa5db9571f69.20103180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7366282-6434-43F3-BF01-3A3F8BF5FC81</gtr:id><gtr:title>Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac75ef233da5a5e7358ca87cf19bb3a4"><gtr:id>ac75ef233da5a5e7358ca87cf19bb3a4</gtr:id><gtr:otherNames>Lai MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>5aaa5db9219a77.11913237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC6E6CE0-CB28-41A6-9230-06E72A871126</gtr:id><gtr:title>Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4c5cb125f1285d8386985420643e6b3"><gtr:id>c4c5cb125f1285d8386985420643e6b3</gtr:id><gtr:otherNames>Sinclair LI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5aaa594aa065d4.71027837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38B1082F-48B2-4F39-8D01-5D56099778A2</gtr:id><gtr:title>Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fac9633f6e624f6001af787ce484c90"><gtr:id>1fac9633f6e624f6001af787ce484c90</gtr:id><gtr:otherNames>James RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>56e15f32471994.79234647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B0ABAAF-AD2F-45A1-9860-C93A5FD10480</gtr:id><gtr:title>Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56e15f376425a1.72188948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>212253C2-63EE-4526-8121-CB257DD4F854</gtr:id><gtr:title>MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dd8b7aba2fbe96680e9ede7ffe1d947"><gtr:id>9dd8b7aba2fbe96680e9ede7ffe1d947</gtr:id><gtr:otherNames>Beevers JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5aaa5f63b925e0.12596405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA20EB95-97DC-4BCD-9FE2-88A262FC34E9</gtr:id><gtr:title>A reduced astrocyte response to ?-amyloid plaques in the ageing brain associates with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0932dcd014438629afa5aaa305271b53"><gtr:id>0932dcd014438629afa5aaa305271b53</gtr:id><gtr:otherNames>Mathur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e15f3555c0b0.94033644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67FF3F5F-C6FC-471F-A28A-FB7ADA7C55AB</gtr:id><gtr:title>Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffea3158c442c8c4965fad81c7e84e64"><gtr:id>ffea3158c442c8c4965fad81c7e84e64</gtr:id><gtr:otherNames>Ugarte A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f39319c42.64017592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B4C9BAA-E6E0-4B25-B31D-E8E5E91AEDA1</gtr:id><gtr:title>Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12ee00bb95ee90e98f1b148708a7684"><gtr:id>f12ee00bb95ee90e98f1b148708a7684</gtr:id><gtr:otherNames>Skrobot OA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58c961d7373556.64022929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAA6BF6B-76C5-465F-B86D-A18EA99A4EED</gtr:id><gtr:title>DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ad98d89b60521faecc397e8f0067925"><gtr:id>3ad98d89b60521faecc397e8f0067925</gtr:id><gtr:otherNames>Trinh J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c962452c2369.74835407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2DBE264-DB8E-4E5D-B880-91C1E9BCD48E</gtr:id><gtr:title>The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b504bd49f0f8f89453b298966c28f062"><gtr:id>b504bd49f0f8f89453b298966c28f062</gtr:id><gtr:otherNames>Yates SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e15f38a35789.58506745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3F85128-FCF9-46C2-89CB-95A343C15DED</gtr:id><gtr:title>The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/707c7227ec5a0ece988817f74b58726a"><gtr:id>707c7227ec5a0ece988817f74b58726a</gtr:id><gtr:otherNames>Sahin P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f353aff84.27513807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88792FE9-6280-42B2-A01F-36D69428C44B</gtr:id><gtr:title>Functional expression of calcium-permeable canonical transient receptor potential 4-containing channels promotes migration of medulloblastoma cells.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e723103971c5723818ceb1e88b167392"><gtr:id>e723103971c5723818ceb1e88b167392</gtr:id><gtr:otherNames>Wei WC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>5aaa64955404d4.39952862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60286308-2010-427F-8B8A-7637D718CE5F</gtr:id><gtr:title>Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498bed82ae06288d048197db7cccb49b"><gtr:id>498bed82ae06288d048197db7cccb49b</gtr:id><gtr:otherNames>Al-Mashhadi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56e15f3c6c5e13.05081378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70CC4BD3-2CCC-43C9-AB6E-E8E74F4A4766</gtr:id><gtr:title>Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b6894bd647acc835ad1a83f9342d6b9"><gtr:id>8b6894bd647acc835ad1a83f9342d6b9</gtr:id><gtr:otherNames>Loveless S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5aaa5dba359932.66166444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D23FCC95-27A9-49A3-B4E3-826C480CDAA9</gtr:id><gtr:title>Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2110c603070779f38f52e27d4feb6d"><gtr:id>af2110c603070779f38f52e27d4feb6d</gtr:id><gtr:otherNames>D'Gama AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>56e15f3af07d09.93998194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FA0FC9D-2CB3-4E94-B082-C3CF6E69EF65</gtr:id><gtr:title>Synaptic proteins predict cognitive decline in Alzheimer's disease and&amp;nbsp;Lewy body dementia.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1369e38121b567ec7098d937373b72ae"><gtr:id>1369e38121b567ec7098d937373b72ae</gtr:id><gtr:otherNames>Bereczki E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58c7f2c54e9bd6.54043612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCD30312-F91C-43E8-9FBE-91CC6EB1BF57</gtr:id><gtr:title>Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce50902b36342c5d081bad54cd06bcad"><gtr:id>ce50902b36342c5d081bad54cd06bcad</gtr:id><gtr:otherNames>Bridges LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>56e15f32d263c8.44887956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9FD574B-783D-4756-B2E8-ABB9D5CDA6D9</gtr:id><gtr:title>Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Molecular neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/331d42cd84ec06a71ca538687acebf2c"><gtr:id>331d42cd84ec06a71ca538687acebf2c</gtr:id><gtr:otherNames>Ferrero H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0893-7648</gtr:issn><gtr:outcomeId>5aaa5db7e116a4.41649096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C465A796-E606-4FF5-9F02-FB9D8904BF27</gtr:id><gtr:title>Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1369e38121b567ec7098d937373b72ae"><gtr:id>1369e38121b567ec7098d937373b72ae</gtr:id><gtr:otherNames>Bereczki E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aaa5eb2c40265.71253529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B37BDA0-E505-4698-B453-522C8CFEB155</gtr:id><gtr:title>Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0399aeccd1b7a51b51d797c1d4d3e5f1"><gtr:id>0399aeccd1b7a51b51d797c1d4d3e5f1</gtr:id><gtr:otherNames>Larkin SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>5464b9ec677736.83503347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97BBCC06-E46D-49F3-AF5B-008C48B980F7</gtr:id><gtr:title>Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4910b85ad214d16d15c09bdceae7a35"><gtr:id>a4910b85ad214d16d15c09bdceae7a35</gtr:id><gtr:otherNames>Janezic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5464bebe9d8b68.20673973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77BBF9C1-057D-499A-AFBB-59B92899212B</gtr:id><gtr:title>Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1da287f55a621cd5e9876bc34531117"><gtr:id>e1da287f55a621cd5e9876bc34531117</gtr:id><gtr:otherNames>Howlett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56e15f378129e8.31221431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0743566-4B3A-4547-A485-6B98F5A6A8F5</gtr:id><gtr:title>ON THE NATURE OF THE TAU R406W MUTATION: INCREASED CIS PSER404-PRO405 AMIDE BOND IN TAU R406W DUE TO A PHOSPHORYLATION-SENSITIVE CIS-PROLINE-AROMATIC INTERACTION</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; Dementia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e2bcad2f056f7401680b5c3bec58db5"><gtr:id>9e2bcad2f056f7401680b5c3bec58db5</gtr:id><gtr:otherNames>Zondlo N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56e15f3829b0a0.09536151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52F1E9D2-62B7-47E7-8D54-1AF29D17B083</gtr:id><gtr:title>Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c24d43f88c99bb3176f7c2871390ba03"><gtr:id>c24d43f88c99bb3176f7c2871390ba03</gtr:id><gtr:otherNames>Taipa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>5aaa5db9e12937.70679504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9B32C01-AE8A-4BF1-A95C-53FE7C4D6C78</gtr:id><gtr:title>Aluminium in brain tissue in autism.</gtr:title><gtr:parentPublicationTitle>Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ee5f62114e84b45f9a9611870c0ad2b"><gtr:id>6ee5f62114e84b45f9a9611870c0ad2b</gtr:id><gtr:otherNames>Mold M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0946-672X</gtr:issn><gtr:outcomeId>5aaa5eb29a5967.61934395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>731EBA5C-5CE7-4DB3-961C-F83B69A924B5</gtr:id><gtr:title>Evaluating fibre orientation dispersion in white matter: Comparison of diffusion MRI, histology and polarized light imaging.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9487f6d9972f831357363183517565e2"><gtr:id>9487f6d9972f831357363183517565e2</gtr:id><gtr:otherNames>Mollink J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5aaa57a96f2ba4.94107801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A90160DF-B50B-4025-BA95-53601EBA8A66</gtr:id><gtr:title>Genome-wide association study of neocortical Lewy-related pathology.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7c17ed5c2cf001307b1ed15341ae8d2"><gtr:id>b7c17ed5c2cf001307b1ed15341ae8d2</gtr:id><gtr:otherNames>Peuralinna T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>56e15f3cb7ae53.20449754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>352FA577-2831-4B3D-8AD5-62175A526A6A</gtr:id><gtr:title>Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67780ae663cf7bf017f910610e6aaf19"><gtr:id>67780ae663cf7bf017f910610e6aaf19</gtr:id><gtr:otherNames>Chai YL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5aaa5db99432d1.09144182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C431C054-668B-40CA-A8DD-2F71B4943488</gtr:id><gtr:title>Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/964e02837b415fc69e32de29f3a448c8"><gtr:id>964e02837b415fc69e32de29f3a448c8</gtr:id><gtr:otherNames>Smith AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c961efd09db8.62917823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>981F6A30-FE03-4A9B-A924-C89F699F00F5</gtr:id><gtr:title>Complement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and Epithelium.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca06078683ff097311e743f26bcd7f6"><gtr:id>4ca06078683ff097311e743f26bcd7f6</gtr:id><gtr:otherNames>Moore GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>58c964054aef19.21159309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C60856D-ADAB-464E-8B38-2B16EC5A7979</gtr:id><gtr:title>Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fd1790b1facf542c4a4b220bd65be15"><gtr:id>8fd1790b1facf542c4a4b220bd65be15</gtr:id><gtr:otherNames>Bullock JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e15f3a7ca386.46822916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0C297A3-8424-43FE-823B-D29FB184AD51</gtr:id><gtr:title>Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878e2d05b1e177f10ea100a84346398f"><gtr:id>878e2d05b1e177f10ea100a84346398f</gtr:id><gtr:otherNames>Lunnon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>56e15f33825873.41817244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAC2AB4F-A6F4-4748-926F-E040D06B9D76</gtr:id><gtr:title>Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48373f99b2b02423cd4dcf74c011d2ea"><gtr:id>48373f99b2b02423cd4dcf74c011d2ea</gtr:id><gtr:otherNames>Grussu F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>5aaa594aecc7d2.00983401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C06A72EA-940A-4451-AD78-0DCC938618B3</gtr:id><gtr:title>Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5464bebe314de8.80532968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20F958BE-6778-4F99-A6DB-0A0B7A2EA886</gtr:id><gtr:title>The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Endocrine pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e12472926b9b64c6b18c47c4cffda3ac"><gtr:id>e12472926b9b64c6b18c47c4cffda3ac</gtr:id><gtr:otherNames>Preda V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1046-3976</gtr:issn><gtr:outcomeId>56e15f34b5dd70.87930343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>337EBC3E-2BEE-45AF-A98C-2972052E7DFF</gtr:id><gtr:title>Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85a3d74a82eccbf09383b78c435a3948"><gtr:id>85a3d74a82eccbf09383b78c435a3948</gtr:id><gtr:otherNames>Patel T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5aaa5db9b8c4e6.58986040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE9D938B-69C5-4AF9-9423-6FA4C0E8C8E9</gtr:id><gtr:title>A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8655b80f35da06543063892dc80fc48b"><gtr:id>8655b80f35da06543063892dc80fc48b</gtr:id><gtr:otherNames>Brady S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>56e15f3aaf4083.39038677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E111352-B8D8-40FD-AD27-161717A1E40E</gtr:id><gtr:title>Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af0764c030d26307aac9e25fbc77623"><gtr:id>3af0764c030d26307aac9e25fbc77623</gtr:id><gtr:otherNames>Geraldes R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5aaa5661352888.17589751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71CDA3B0-D2D8-4FEE-9F87-40991F48B083</gtr:id><gtr:title>Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11f6020b757bd989fc204657e8aabfac"><gtr:id>11f6020b757bd989fc204657e8aabfac</gtr:id><gtr:otherNames>Waite AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e15f367ebf66.42230398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9060FA30-ABF3-40A6-9D5C-9209D3B00C56</gtr:id><gtr:title>Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373ede94ea3c44d7eca786be0b2c1d90"><gtr:id>373ede94ea3c44d7eca786be0b2c1d90</gtr:id><gtr:otherNames>Whitfield DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e15f379d0d70.59429339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C21887D2-FFB7-4603-85CC-F957C8E91487</gtr:id><gtr:title>Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f57af54aaf68af39c7fb8a5b1854743"><gtr:id>1f57af54aaf68af39c7fb8a5b1854743</gtr:id><gtr:otherNames>Garwood C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f369f9991.16274821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C0BFA96-52E1-42C5-B8B9-1EB3DE780351</gtr:id><gtr:title>Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65378619cf887eea1aee93de2b16196b"><gtr:id>65378619cf887eea1aee93de2b16196b</gtr:id><gtr:otherNames>Jones EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56e15f34260166.18373452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5254582C-B818-422D-ACA1-F0BBA698BC31</gtr:id><gtr:title>Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia.</gtr:title><gtr:parentPublicationTitle>European archives of psychiatry and clinical neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334f16951581ac0cc09c785da953e2cc"><gtr:id>334f16951581ac0cc09c785da953e2cc</gtr:id><gtr:otherNames>Williams M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0940-1334</gtr:issn><gtr:outcomeId>5464c090032c43.83309667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8464CFF-E1C3-4038-97EF-CD3AD061D9BC</gtr:id><gtr:title>Histone Acetylome-wide Association Study of Autism Spectrum Disorder.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0583eb584340b0d99bc1c77ac6e0020"><gtr:id>e0583eb584340b0d99bc1c77ac6e0020</gtr:id><gtr:otherNames>Sun W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58c9642b09cd16.11062450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>933A74D3-29ED-4F86-B651-528A0C9D249A</gtr:id><gtr:title>Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ca7019f78cb8df1af2661d6618ed2ff"><gtr:id>5ca7019f78cb8df1af2661d6618ed2ff</gtr:id><gtr:otherNames>Emir UE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>56e15f3a617b05.33591678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96CF0982-1BD2-4900-A734-EECD106E095B</gtr:id><gtr:title>Age-dependent expression of VEGFR2 in deep brain arteries in small vessel disease, CADASIL, and healthy brains.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a7a11e894bd7c7d8c194a37e19b64e4"><gtr:id>1a7a11e894bd7c7d8c194a37e19b64e4</gtr:id><gtr:otherNames>Ahmed-Jushuf F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>585d693c256c92.09929958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B15A59E6-AB6E-4D40-A8E4-734BFE429FAB</gtr:id><gtr:title>STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dfa90d41cd3725a06677b3ce6b0b7b0"><gtr:id>9dfa90d41cd3725a06677b3ce6b0b7b0</gtr:id><gtr:otherNames>Turnquist C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56e15f37e01b11.01637372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>648503E8-C904-4F14-BD02-7F0F00E5BB6E</gtr:id><gtr:title>Improved localisation for 2-hydroxyglutarate detection at 3T using long-TE semi-LASER.</gtr:title><gtr:parentPublicationTitle>Tomography : a journal for imaging research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0220c1458cc928948f564eae49036804"><gtr:id>0220c1458cc928948f564eae49036804</gtr:id><gtr:otherNames>Berrington A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c7f33dc49138.95485180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86C604E6-4B04-4357-9F30-F386476CFE1F</gtr:id><gtr:title>Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56e15f3c86e5e0.39952818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6EEFFD1-0A38-4D99-9B88-9041E9EE79D4</gtr:id><gtr:title>Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease.</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1266e13891833cffd893188adf57047d"><gtr:id>1266e13891833cffd893188adf57047d</gtr:id><gtr:otherNames>Cadieux-Dion M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>5464bebe553291.48737173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD146BD-5A6B-46E9-8D79-364E00F79CC9</gtr:id><gtr:title>Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with A? burden.</gtr:title><gtr:parentPublicationTitle>Neurochemistry international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9302ad5f3c182c196539d5978ed5a1f0"><gtr:id>9302ad5f3c182c196539d5978ed5a1f0</gtr:id><gtr:otherNames>Tan MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-0186</gtr:issn><gtr:outcomeId>56e15f352084e3.74330617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB9CFF87-72CB-4A8E-AC84-D8146B1ED5B5</gtr:id><gtr:title>Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with ?-amyloid burden and synaptic deficits in Lewy body dementias.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/615885f69719bbad33a4a8c46a53beb3"><gtr:id>615885f69719bbad33a4a8c46a53beb3</gtr:id><gtr:otherNames>Xing H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>58c962c2c4ff83.16186340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B1135A0-7EB5-4B07-B9A4-A9D1FD581FCA</gtr:id><gtr:title>A framework for optimal whole-sample histological quantification of neurite orientation dispersion in the human spinal cord.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48373f99b2b02423cd4dcf74c011d2ea"><gtr:id>48373f99b2b02423cd4dcf74c011d2ea</gtr:id><gtr:otherNames>Grussu F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>58c963790b2464.78260145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>842FCC24-7B0A-4B3D-A399-865ED6B6728C</gtr:id><gtr:title>Deubiquitinase Usp8 regulates a-synuclein clearance and modifies its toxicity in Lewy body disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/162419e29842279e59d36a09904fe1b5"><gtr:id>162419e29842279e59d36a09904fe1b5</gtr:id><gtr:otherNames>Alexopoulou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c7f28edcf7a8.79549525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA28A44E-CA97-4B62-A51F-0D85B96A2627</gtr:id><gtr:title>Hippocampal sclerosis, hippocampal neuron loss patterns and Tdp-43 in the aged population.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a31e68f18d1b2deaf7c8ae9f1391e868"><gtr:id>a31e68f18d1b2deaf7c8ae9f1391e868</gtr:id><gtr:otherNames>Hokkanen SRK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5aaa594b1c7ba7.51149141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E362AE4C-0B0D-41C8-896B-58064C94ECA6</gtr:id><gtr:title>The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2a4c7ede55899808f1991361463fd09"><gtr:id>c2a4c7ede55899808f1991361463fd09</gtr:id><gtr:otherNames>Fluteau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>56e15f39cb1769.27269545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36AEF8D3-34AC-4244-B983-8C1947ADC7F9</gtr:id><gtr:title>Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d82cea2455b997724bf26606df3e21db"><gtr:id>d82cea2455b997724bf26606df3e21db</gtr:id><gtr:otherNames>Baruch K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e15f3a443650.99063731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>982AB66C-2982-475E-BA57-CDAAB0BAA95A</gtr:id><gtr:title>Generation and characterization of novel conformation-specific monoclonal antibodies for a-synuclein pathology.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68baf4c5e80f2ecf30db7f043904e34d"><gtr:id>68baf4c5e80f2ecf30db7f043904e34d</gtr:id><gtr:otherNames>Vaikath NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>56e15f3b208123.26158050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7C8A13A-A9B8-49AA-ABB8-D9917582C556</gtr:id><gtr:title>Complement is activated in progressive multiple sclerosis cortical grey matter lesions.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ab9ad82b9ec01fbcc579e47d2680a8"><gtr:id>55ab9ad82b9ec01fbcc579e47d2680a8</gtr:id><gtr:otherNames>Watkins LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>58c962a6b884c7.93534956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D0EB34C-3194-4A86-953A-965EF24D389C</gtr:id><gtr:title>Primary olfactory cortex in autism and epilepsy: increased glial cells in autism.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a17384417936099179eb1ec0ab255c19"><gtr:id>a17384417936099179eb1ec0ab255c19</gtr:id><gtr:otherNames>Menassa DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>58c963ecd3d6c1.46836873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57AA5ECD-294A-43D5-A9C0-C625D5E36646</gtr:id><gtr:title>Jagged1 Is Altered in Alzheimer's Disease and Regulates Spatial Memory Processing.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8412cfc1668a23437af762d232003c3b"><gtr:id>8412cfc1668a23437af762d232003c3b</gtr:id><gtr:otherNames>Marathe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5102</gtr:issn><gtr:outcomeId>5aaa5db8585d00.70986192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D90EA3DE-547E-44F0-B86A-66FBBF3BC179</gtr:id><gtr:title>Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db87190247ff1f7e0103515a961c4862"><gtr:id>db87190247ff1f7e0103515a961c4862</gtr:id><gtr:otherNames>Gatt AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>56e15f32b3ee19.18399410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F62D9D6-FD58-4E9B-ACB1-176249D673FF</gtr:id><gtr:title>TREM2 expression in the human brain: a marker of monocyte recruitment?</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/084ba9ba8ab07493615a7ed3551670a6"><gtr:id>084ba9ba8ab07493615a7ed3551670a6</gtr:id><gtr:otherNames>Fahrenhold M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>5aaa5db8e260e8.55945666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41919345-90B3-4173-B9CA-2C79307982CE</gtr:id><gtr:title>Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373ede94ea3c44d7eca786be0b2c1d90"><gtr:id>373ede94ea3c44d7eca786be0b2c1d90</gtr:id><gtr:otherNames>Whitfield DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>56e15f349a1879.43089950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EF23160-1ED3-43C3-9BE2-876E71B0EE41</gtr:id><gtr:title>Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db87190247ff1f7e0103515a961c4862"><gtr:id>db87190247ff1f7e0103515a961c4862</gtr:id><gtr:otherNames>Gatt AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56e15f39036bd6.03419712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFBD7325-94D1-4171-BBBF-D95BFA3240B2</gtr:id><gtr:title>Adrenomedullin Contributes to Age-Related Memory Loss in Mice and Is Elevated in Aging Human Brains.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d4917f37a91685254cb5572739bc877"><gtr:id>2d4917f37a91685254cb5572739bc877</gtr:id><gtr:otherNames>Larrayoz IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>5aaa594ac8ab44.38758083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB2297C-38F2-4A9A-897F-74E8826A10F5</gtr:id><gtr:title>Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5436fd0791428cc8836e607d3b06380a"><gtr:id>5436fd0791428cc8836e607d3b06380a</gtr:id><gtr:otherNames>Iacovazzo D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58c9610a818968.12499590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7068B403-69E6-4F22-BFA9-2BBE3890ADA8</gtr:id><gtr:title>(I) Pharmacological profiling of a novel modulator of the a7 nicotinic receptor: Blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd06e9c5ebfdd23c0db99fbb380f090d"><gtr:id>cd06e9c5ebfdd23c0db99fbb380f090d</gtr:id><gtr:otherNames>Garcia-Rat?s S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>56e15f3cdc12b4.85281751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67B4D71C-97FB-4551-8D64-6A8BFD3E5BF6</gtr:id><gtr:title>Improving diffusion-weighted imaging of post-mortem human brains: SSFP at 7 T.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8777f3021386d9775d4c41d54da7535c"><gtr:id>8777f3021386d9775d4c41d54da7535c</gtr:id><gtr:otherNames>Foxley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56e15f3d56a485.28219035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D1C38D-1245-4F60-9CFB-40C63C5A7614</gtr:id><gtr:title>The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fd5e18287c87877fcd6015f06a75237"><gtr:id>4fd5e18287c87877fcd6015f06a75237</gtr:id><gtr:otherNames>Medway C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>56e15f3bd4cb92.27667703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A6470B3-ED35-458E-A664-954F78312B81</gtr:id><gtr:title>Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d701cd80451e6067dc025280135c8c99"><gtr:id>d701cd80451e6067dc025280135c8c99</gtr:id><gtr:otherNames>Vallortigara J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>56e15f32951f73.40404491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1E5CAC9-C536-4F68-B1CD-1FA202A0B26D</gtr:id><gtr:title>Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a1f56e8de5a7adc48f75f029ab3101d"><gtr:id>4a1f56e8de5a7adc48f75f029ab3101d</gtr:id><gtr:otherNames>Alghamdi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5aaa5dba137b39.02833173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C0D47D6-713F-45FE-BD22-5BAE17D246BF</gtr:id><gtr:title>Choice of reference measurements affects quantification of long diffusion time behaviour using stimulated echoes.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc6bbceec394d70d6242aa5b69afeab"><gtr:id>cfc6bbceec394d70d6242aa5b69afeab</gtr:id><gtr:otherNames>Kleinnijenhuis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5aaa594a661bb1.28660070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>170951A6-1AF8-4840-9126-F46BAAA8635F</gtr:id><gtr:title>Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0567f8eebf7db3e5c72de58de70706ff"><gtr:id>0567f8eebf7db3e5c72de58de70706ff</gtr:id><gtr:otherNames>Lee JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>56e15f380bfc60.37993685</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L022656/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>